Anemia management in patients on peritoneal dialysis: efficacy and safety of epoetin δ
In a one-year, multicenter, open-label, uncontrolled trial, epoetin δ was given subcutaneously, 1–3-times weekly to peritoneal dialysis patients who had previously received an epoetin. Dose was adjusted to maintain hemoglobin at 10.0–12.0 g/dL. The primary endpoint was mean hemoglobin over weeks 12–...
| Κύριος συγγραφέας: | |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
Ferrata Storti Foundation
2008-05-01
|
| Σειρά: | Haematologica |
| Διαθέσιμο Online: | https://haematologica.org/article/view/4851 |